Sign inJoin waitlistJoin the waitlist

Christie Ballantyne

Section Chief of Cardiology and Cardiovascular Research · Baylor College of Medicine

Credentials: · · · · · ·

History

Cardiology and Cardiovascular Research Section · Baylor College of Medicine
Present
Cardiology Division · Baylor College of Medicine
Present
Center for Cardiometabolic Disease Prevention · Baylor College of Medicine
Present

Baylor College of Medicine Affiliate Hospitals
1985–1988
University Of Texas Southwestern Affiliate Hospitals
1982–1985
Baylor College of Medicine
1978–1982
University of Texas at Austin
1974–1978

Research

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
New England Journal of Medicine · 2017 · 7,723 citations
Biological, clinical and population relevance of 95 loci for blood lipids
Systematic review or meta-analysis · Nature · 2010 · 2,901 citations
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
New England Journal of Medicine · 2019 · 2,455 citations

Vijay Nambi
219 papers · 5 as a fellow
Salim Virani
210 papers
AF
Aaron Folsom
76 papers
Laura Petersen
60 papers
CN
Chiadi Ndumele
54 papers
Bruce Psaty
52 papers
James de Lemos
50 papers
Deepak Bhatt
46 papers
Amil Shah
42 papers
Jerome Rotter
42 papers
Erin Michos
41 papers
TJ
Terry Jacobson
39 papers

Grants

Clonal Hematopoiesis in Humans: Determinants of Development and Progression
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.9M · Baylor College of Medicine
2019–2025
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.1M · Baylor College of Medicine
2016–2021
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) - Domestic Site - Phase 3
National Heart, Lung, and Blood Institute · N01
Contact PI · $6.1M · Yale University
2010–2016
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.7M · Baylor College of Medicine
2009–2015

Clinical trials

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
Principal investigator · Completed · Phase 3
AstraZeneca
2007–2008
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Principal investigator · Completed · Phase 4
Baylor College of Medicine
2004–2010
Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
Study director · Completed · Phase 4
Baylor College of Medicine
2007–2008
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2026–2030